Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Observational, Drug-utilization Study in Belgium to Evaluate the Use of VIMPAT® in Clinical Practice as Adjunctive Treatment of Partial Onset Epilepsy in Subjects Aged 16 and Older.

NCT01236001 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT01236001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01236001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Observational, Drug-utilization Study in Belgium to Evaluate the Use of VIMPAT® in Clinical Practice as Adjunctive Treatment of Partial Onset Epilepsy in Subjects Aged 16 and Older.
Lead sponsor
UCB Pharma
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
March 31, 2012
Enrollment
192 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

seizures